Lithotripsy Device Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Lithotripsy Device Market is Segmented by Type (Extracorporeal Shock Wave Lithotripsy Devices and Intracorporeal Lithotripsy Devices), Application (Kidney Stones, Ureteral Stones, Pancreatic Stones and, Bile Duct Stones), End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Lithotripsy Device Market Bar Graph
Study Period: 2018-2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The lithotripsy devises market was valued at approximately USD 1.58 billion in 2020, and it is expected to reach USD 2.04 billion by 2026, registering a CAGR of 4.3% during the forecast period, 2021-2026.

The market is primarily driven by the increasing incidence of urolithiasis, rise in the number of extracorporeal shock waves lithotripsy procedures, and technological advancements coupled with rising awareness. The COVID-19 pandemic has severely impacted the lithotripsy devices market, as anesthesiologists were needed to manage patients in acute COVID-19 crisis and, therefore, had to withdraw from elective surgery. The number of beds used for urological patients had to be reduced to dedicate beds and personnel to the new COVID-19 wards. Also, there was a need to not infect elective patients via hospital contamination. Most importantly, from a urological perspective, most of the residual urological medical staff became entirely dedicated to managing the infected patients on the newly formed COVID-19 ward. Hence, the growing COVID-19 patient pool and lesser number of elective surgeries impacted the market in 2020.

Urolithiasis is a common urologic problem, and it poses a significant burden on the healthcare system globally. It is associated with an increased risk of end-stage renal failure, which is driving the demand for lithotripsy devices. As per the European Association of Urology, 2019, the prevalence rates for urinary stones vary from 1% to 20%. In countries with a high standard of life, such as Canada, Sweden, or the United States, renal stone prevalence is notably high (> 10%). For some areas, an increase of more than 37% has been reported over the last 20 years. It has been associated with an increased risk of end-stage renal failure. Thus, the increasing global prevalence of urolithiasis necessitates safe, efficacious, and affordable treatment for urolithiasis.

Over the years, lithotripsy has become the most preferred method for the treatment of kidney stones, largely due to the advantage of its relative safety, low cost, less recovery time, and positive patient outcomes. Thus, all these factors are responsible for driving the growth of the market studied.

However, apart from several advantages of the treatment, there are several risks associated with the lithotripsy treatment. This treatment sometimes leads to internal bleeding and may need a blood transfusion. It can lead to adverse side effects, where the kidney may get damaged due to blockage in the flow of urine passage caused by tiny stone particles. There are complications, such as high blood pressure, which also restrain the market. Also, the adverse effects of lithotripsy shock waves often result in hypertension, diabetes, and, in some cases, permanent loss of functional renal volume, which act as major barriers for the lithotripsy devices market.

Scope of the Report

As per the scope of the report, lithotripsy is a procedure that uses shock waves to break up the stones in the kidney, bladder, or ureter. After the procedure, the tiny pieces of stones pass out of the body through the process of urination. However, large-sized stones are not able to pass through routine urination. Thus, the formation of stones can lead to bleeding, severe pain in the urinary tract, infection, and kidney damage. The lithotripsy device market is segmented by type (extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices), application (kidney stones, ureteral stones, pancreatic stones and, bile duct stones), end user (hospitals, ambulatory surgical centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Type
Extracorporeal Shock Wave Lithotripsy Devices
Intracorporeal Lithotripsy Devices
Laser Lithotripsy Devices
Electrohydraulic Lithotripsy Devices
Ultrasonic Lithotripsy Devices
Pneumatic (Ballistic) Lithotripsy Devices
By Application
Kidney Stones
Ureteral Stones
Pancreatic Stones
Bile Duct Stones
By End User
Ambulatory Surgical Centers
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Extracorporeal Shock Wave Lithotripsy (ESWL) Devices Segment is Expected to Have a Significant Share in the Market

Extracorporeal shock wave lithotripsy is a technique for treating stones in the kidney and ureter that do not require surgery. Instead, high-energy shock waves are passed through the body and used to break stones into pieces as small as grains of sand. The extracorporeal shock wave lithotripsy devices (ESWL) are used for the treatment of kidney and ureter stones. This technology has been utilized by physicians worldwide and is expected to increase its penetration over the coming years due to the advantages offered by such as minimal invasiveness, reduced pain, and shorter hospital stay, and quicker recovery time.

With the growing cases of COVID-19, there is a lesser number of urology surgeries being performed that has also reduced the number of extracorporeal shock wave lithotripsy (ESWL) devices during this time, which is anticipated to have a slight negative impact on the market.

It is the most common lithotripsy performed outside the body, which refers to the shock wave treatment. During extracorporeal shock wave lithotripsy (ESWL), a special machine known as lithotripter, generates high-energy shock waves such as sound waves, X-ray, or ultrasound, which pass through the body until they hit the kidney stones.

However, it was found that ESWL was first performed in the United States. However, it has been reported that some patients may not experience a successful outcome following ESWL. ESWL, however, is only used in selected stones in the kidney and ureter. Therefore, it does not apply to all stone types or locations. Generally, this procedure is considered safe and less time-consuming, it takes only 45 minutes to perform. The growing demand for non-invasive procedures is leading to the adoption of ESWL.

Hence, with the growing kidney-related disorders, coupled with rising awareness, across the globe are likely to augment the market growth over the forecast period.

Lithotripsy Device Market Share

North America Holds the Largest Share of the Lithotripsy Device Market

In North America, the lithotripsy devices market is projected to witness growth over the forecast period. Chronic kidney diseases are estimated to be common in women than in men. The number of chronic kidney diseases is found increasing globally. Kidney disease statistics for the United States convey the burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD).

The outbreak of COVID-19 has had a negative impact on the lithotripsy devices market due to the reduced number of surgeries being performed during the COVID-19 that also resulted in reduced usage of the devices. COVID-19 has also affected the market by directly affecting production and demand by creating supply chain and market disruption and financial impact on firms and financial markets.

According to the Centers for Disease Control and Prevention, 2019, around 37 million people, i.e., 1 out of every 7, or 15% of the adult population, were estimated to have chronic kidney diseases. With the increasing cases of kidney diseases, over 50,000 lithotripsy procedures are completed annually in the United States, which helps in driving the lithotripsy devices market.

Also, in January 2019, Shockwave Medical launched a US pivotal trial for its coronary lithotripsy device, which is designed to prepare heavily calcified coronary lesions for stenting. This technology uses sonic pressure waves to fracture intimal and medial calcium without damaging arterial tissue, which is likely to expand the company’s business and help in driving the lithotripsy devices market in the country.

Hence, during the forecast period, the region's share of the global market is likely to grow significantly, owing to the high prevalence and the treatments of kidney stone disease in the United States. Also, product launches, acquisitions, and collaborations are expected to promote the regional market.

Lithotripsy Device Market Growth Rate By Region

Competitive Landscape

The lithotripsy device market is found to be competitive. The key market players operating in lithotripsy devices are EDAP TMS, Boston Scientific Corporation, Olympus Corporation, Accuron, and DirexGroup, among others. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them strengthen their market positions. Furthermore, companies also focusing on the widening applications of lithotripsy devices to strengthen their positions over the forecast period.

Recent Developments

In July 2020, Lumenis Ltd announced the launch of MOSES 2.0, the next generation of the versatile, patented MOSES platform that is redefining urology care. MOSES 2.0 builds on the already clinically proven advantages of the MOSES technology platform to continue to push the boundaries in terms of procedure outcomes, efficiency, and economics.

In October 2020, JIPMER installed a new advanced Extracorporeal Shock-Wave Lithotripsy System (Dornier Delta III) in the Department of Urology that brings relief to kidney stone patients.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Urolithiasis

      2. 4.2.2 Rise in Number of Extracorporeal Shock Wave Lithotripsy Procedures

      3. 4.2.3 Technological Advancements in Minimally Invasive Surgeries

    3. 4.3 Market Restraints

      1. 4.3.1 Adverse Effects Associated with Lithotripsy

      2. 4.3.2 Availability of Alternative Treatments for Stone Removal

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Type

      1. 5.1.1 Extracorporeal Shock Wave Lithotripsy Devices

      2. 5.1.2 Intracorporeal Lithotripsy Devices

        1. Laser Lithotripsy Devices

        2. Electrohydraulic Lithotripsy Devices

        3. Ultrasonic Lithotripsy Devices

        4. Pneumatic (Ballistic) Lithotripsy Devices

    2. 5.2 By Application

      1. 5.2.1 Kidney Stones

      2. 5.2.2 Ureteral Stones

      3. 5.2.3 Pancreatic Stones

      4. 5.2.4 Bile Duct Stones

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 EDAP TMS

      2. 6.1.2 Electro Medical Systems SA (Boston Scientific Corporation)

      3. 6.1.3 Olympus Americas

      4. 6.1.4 Dornier MedTech

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Storz Medical AG

      7. 6.1.7 Cook Medical LLC

      8. 6.1.8 Walz Elektronik GmbH

      9. 6.1.9 Novamedtek

      10. 6.1.10 Elmed Medical Systems

      11. 6.1.11 Karl Storz SE & Co. KG

      12. 6.1.12 Siemens Healthineers AG

      13. 6.1.13 Richard Wolf GmbH

      14. 6.1.14 DirexGroup

      15. 6.1.15 Lumenis

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Lithotripsy Device Market market is studied from 2018 - 2026.

The Global Lithotripsy Device Market is growing at a CAGR of 4.3% over the next 5 years.

The Global Lithotripsy Device Market is valued at 1580 Million USD in 2018.

The Global Lithotripsy Device Market is valued at 2040 Million USD in 2026.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

EDAP TMS, DirexGroup, Boston Scientific Corporation, Olympus Corporation, Cook Medical LLC are the major companies operating in Global Lithotripsy Device Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!